Showing results (301-310 of 325) with videos related to

Sort By:
Pageof 33
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
A humanized antibody that binds to the interleukin 2 receptorC Queen, W P Schneider, H E Selick, et al.
Pediatric Surgery International|February 10, 2017
Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung diseaseJ C Langer, M D Rollins, M Levitt, et al.
Infection and Immunity|July 5, 2017
Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic CardiomyopathyVanaja Konduri, Matthew M Halpert, Dan Liang, et al.
Cancer Treatment Reports|March 1, 1987
Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatinJ L Pater, J A Carmichael, G V Krepart, et al.
Cancer Immunology, Immunotherapy : CII|June 14, 2017
Phase I trial of antigen-targeted autologous dendritic cell-based vaccine with in vivo activation of inducible CD40 for advanced prostate cancerGuru Sonpavde, John D McMannis, Yu Bai, et al.
Cancer Research|December 6, 2013
FGFR1-WNT-TGF-β signaling in prostate cancer mouse models recapitulates human reactive stromaJulienne L Carstens, Payam Shahi, Susan Van Tsang, et al.
Cancer Informatics|June 2, 2022
Semi-Automated Computational Assessment of Cancer Organoid Viability Using Rapid Live-Cell MicroscopyJoseph D Buehler, Cylaina E Bird, Milan R Savani, et al.
The Journal of Urology|February 19, 2008
A comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA ConsortiumChris Mullins, M Scott Lucia, Simon W Hayward, et al.
Cancer Gene Therapy|January 24, 2019
Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcomaV Konduri, M M Halpert, Y C Baig, et al.
Frontiers in Immunology|January 31, 2018
AIMp1 Potentiates TH1 Polarization and Is Critical for Effective Antitumor and Antiviral ImmunityDan Liang, Lin Tian, Ran You, et al.
Pageof 33